Confronti finanziari Hansa Biopharma AB

Azioni

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 18:00:00 12/06/2026			Variaz. 5gg	Var. 1 gen.
34,48 ^SEK	+6,95%		+11,80%	+0,35%

10/06	Borsa di Stoccolma: apertura prevista intorno alla parità	FW
10/06	Hansa Biopharma nomina un nuovo responsabile del Business Development proveniente da AstraZeneca	FW

Aggiungi a una lista 0 selezionato Solo clienti o iscritti possono usare questa funzione Accedi Registrati	Fatturato (Y-1)	Margine netto (Y-1)	Margine EBIT (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
HANSA BIOPHARMA AB	24,11 Mln	-238,12%	-234,27%	-	-	-0.18x
LONZA GROUP AG	8,24 Mrd	14,53%	21,7%	10,28%	4,9%	1.58x
IQVIA HOLDINGS INC.	16,31 Mrd	8,34%	13,38%	32,9%	4,79%	3.63x
BEONE MEDICINES AG	5,34 Mrd	5,37%	8,37%	29,84%	16,27%	-5.99x
CELLTRION, INC.	2,88 Mrd	24,74%	28,07%	5,94%	4,75%	1.77x
ASCENDIS PHARMA A/S	846 Mln	-31,67%	-18,92%	-	-	1.57x
MEDPACE HOLDINGS, INC.	2,53 Mrd	17,83%	20,93%	70,23%	22,13%	-0.89x
EUROFINS SCIENTIFIC SE	8,57 Mrd	6,51%	14,79%	9,61%	4,34%	2.22x
IONIS PHARMACEUTICALS, INC.	944 Mln	-40,36%	-40,47%	-70,72%	-11,67%	4.51x
ICON PUBLIC LIMITED COMPANY	8,25 Mrd	2,78%	16,66%	10,62%	6,02%	1.8x
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	4,02 Mrd	-3,59%	19,77%	15,46%	6,99%	1.98x
TEMPUS AI, INC.	1,27 Mrd	-19,27%	-3,71%	-38,64%	-6,61%	-65.61x
BIO-TECHNE CORPORATION	1,22 Mrd	6,02%	31,45%	15,37%	11,65%	0.43x
ABIVAX	5,4 Mln	-7.306,52%	-5.350%	-135,58%	-	2.1x
QIAGEN N.V.	2,09 Mrd	20,33%	29,46%	17,5%	10,73%	0.74x
ALKERMES PLC	1,48 Mrd	16,37%	17,21%	14,72%	10,64%	-2.06x
KYMERA THERAPEUTICS, INC.	39,21 Mln	-794,04%	-891,07%	-25,78%	-22,89%	4.75x
Media	3,77 Mrd	-488,87%	-371,57%	-2,55%	4,43%	-2,80x
Media ponderata per Capi.	5,75 Mrd	-249,96%	-183,62%	7,38%	5,91%	-1,38x